Enovis acquired Insight Medical Systems, a technology company dedicated to reimagining orthopedic surgical guidance. Insight’s flagship solution, ARVIS® (Augmented Reality Visualization and Information System), is reported to be the only FDA-cleared augmented reality solution that is engineered for the specific needs of hip and knee replacement surgery. Financial terms of the transaction were not disclosed.
ARVIS will be commercially available in 3Q22, and the Insight™ team will become part of the Enovis Surgical organization (previously DJO Surgical).
“We are excited to welcome Insight’s talented team to our Enovis family where we will work together to improve patient outcomes through the use of next generation augmented reality surgical guidance in orthopedic surgery,” said Matt Trerotola, CEO of Enovis. “Adding Insight’s technology to our rapidly growing Surgical business advances our enabling technologies platform with innovation tailored to today’s healthcare economics and especially the ASC.”
“ARVIS delivers real-time, hands-free surgical guidance at the point of care and is designed to generate measurably better patient outcomes in a streamlined, space-conserving and cost-effective manner compared to traditional robotic offerings,” explains Brady Shirley, COO of Enovis. “Simply put, the ARVIS Augmented Reality System represents the next era of orthopedic technology, and we look forward to expanding its features and reach while integrating additional joint replacement surgery capabilities in the future.”
Enovis acquired Insight Medical Systems, a technology company dedicated to reimagining orthopedic surgical guidance. Insight’s flagship solution, ARVIS® (Augmented Reality Visualization and Information System), is reported to be the only FDA-cleared augmented reality solution that is engineered for the specific needs of hip and knee replacement...
Enovis acquired Insight Medical Systems, a technology company dedicated to reimagining orthopedic surgical guidance. Insight’s flagship solution, ARVIS® (Augmented Reality Visualization and Information System), is reported to be the only FDA-cleared augmented reality solution that is engineered for the specific needs of hip and knee replacement surgery. Financial terms of the transaction were not disclosed.
ARVIS will be commercially available in 3Q22, and the Insight™ team will become part of the Enovis Surgical organization (previously DJO Surgical).
“We are excited to welcome Insight’s talented team to our Enovis family where we will work together to improve patient outcomes through the use of next generation augmented reality surgical guidance in orthopedic surgery,” said Matt Trerotola, CEO of Enovis. “Adding Insight’s technology to our rapidly growing Surgical business advances our enabling technologies platform with innovation tailored to today’s healthcare economics and especially the ASC.”
“ARVIS delivers real-time, hands-free surgical guidance at the point of care and is designed to generate measurably better patient outcomes in a streamlined, space-conserving and cost-effective manner compared to traditional robotic offerings,” explains Brady Shirley, COO of Enovis. “Simply put, the ARVIS Augmented Reality System represents the next era of orthopedic technology, and we look forward to expanding its features and reach while integrating additional joint replacement surgery capabilities in the future.”
Copy to clipboard 
